Early during MAPK inhibition, melanomas often display increased melanoma antigen expression and enhanced CD8<sup>+</sup> T-cell infiltration, along with reduced immunosuppressive cytokines, suggesting a transient "immune-permissive" window. Here, CD8A is linked to melanoma.